pharma · Retinitis Pigmentosa · Dry Eye Disease · KPRX
KIORA PHARMACEUTICALS
KIORA PHARMACEUTICALS INC
KIORA PHARMACEUTICALS patent portfolio — 4 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Encinitas, USA
- Founded
- 2013
- Employees
- 18
- Programs
- 5
- Drugs
- 4
- Patents
- 4
KIORA PHARMACEUTICALS patents
4 pharmaceutical patents indexed for KIORA PHARMACEUTICALS. 0 expire within 24 months.
KIORA PHARMACEUTICALS has 4 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12364680
Compounds for treating ophthalmic diseases and disorders
granted -
US 12209073
Polymorphs of a dihydroorotate dehydrogenase (DHOD) inhibitor
granted -
US 11730716
Compounds for treating ophthalmic diseases and disorders
granted -
US 11376214
Compositions and methods for treatment of ocular diseases
granted
Frequently asked questions
How many patents does KIORA PHARMACEUTICALS have?
4 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do KIORA PHARMACEUTICALS patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.